After 3 repeated solicitations, only one PI provided us with the full data on CYP1A2 SNPs of breast cancer cases and controls, and by this making total of 71 studies included in our meta-analyses [4, 7–52, 61–84]. This evidence concerns the gene CYP1A2 and breast cancer.